STJ  St. Jude Medical Inc.




Health Care


Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.


Vuru Grade


Current Price

+0.69 (+1.10%)

Growth Price

Overvalued by 15.23%

Stability Price

Overvalued by 67.80%

Company Metrics

  • P/E 18.09
  • P/S 3.22
  • P/B 4.45
  • EPS 3.52
  • Cash ROIC 14.54%
  • Cash Ratio 0.54
  • Dividend 1.16 / 1.84 %
  • Avg. Vol. 1.80M
  • Shares 282.60M
  • Market Cap. 17.99B

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Today St. Jude Medical, Inc. Stock Increases. What To Expect? - 9 hours ago
The stock of St. Jude Medical, Inc. (NYSE:STJ) gapped up by $0.01 today and has $97.40 target or 53.00% above today's $63.66 share price.
St. Jude Medical Inc. (NYSE:STJ) - Large Cap Afternoon Report - Wall Street Observer
Institutional Investors Lead Shift in ST Jude Medical Inc (NYSE:STJ) Sentiment - Voice Chronicle
St. Jude Medical Inc. (NYSE:STJ) - Large Cap Morning Report
Wall Street Observer - Nov 26, 2015
St. Jude Medical Inc. (NYSE:STJ), of the Healthcare sector was at a price of 62.97 today, marking a change of 0.30%.
St. Jude Medical lowers earnings outlook
Minneapolis Star Tribune - Oct 21, 2015
St. Jude Medical Inc. shares closed down more than 8 percent Wednesday as the medical device manufacturer trimmed its financial outlook on disappointing news about two key heart devices.
Why St. Jude Medical (STJ) Stock Is Down Today -
Analyst Price Target Update on St. Jude Medical, Inc. (NYSE:STJ) - Money Flow Index
St. Jude Medical Inc (NYSE:STJ) Had Its TP Lowered by 3.85 % at Barclays ... - Nov 24, 2015
In a research note sent to investors by Barclays Capital on 23 November, St. Jude Medical Inc (NYSE:STJ) had its PT cut to $75.00.
Are Analysts Bullish St. Jude Medical, Inc. (NYSE:STJ) After Last Week? -
St. Jude Medical Announces Leadership Transition Plan
Business Wire (press release) - Sep 9, 2015
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced that its Board of Directors has implemented a leadership transition plan that capitalizes on the strength of the St. Jude Medical management team.
St. Jude Medical CEO stepping down; successor named - Minneapolis / St. Paul Business Journal
UPDATE 1-St. Jude Medical CEO Daniel Starks to retire in January - Reuters
Trade of the Day: STJ Stock Looks Like a Gem - Sep 17, 2015
St. Jude Medical, Inc. (STJ) - This leading maker of heart valves, pacemakers, defibrillators, and other cardiac devices has been the subject of takeover rumors from time to time.
Company Shares of St. Jude Medical, Inc. (NYSE:STJ) Rally 0.15%
American Trade Journal - Nov 23, 2015
Shares of St. Jude Medical, Inc. (NYSE:STJ) appreciated by 0.15% during the past week but lost 1.48% on a 4-week basis.
Morningstar Gives A Credit Rating to St. Jude Medical (STJ) - MidSouth Newz
St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a ...
Business Wire (press release) - Nov 19, 2015
BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company and an international leader in chronic pain therapy development, today announced FDA approval of the new Proclaimâ„¢ Elite Spinal Cord Stimulation System, the first ...
St. Jude Medical Gets FDA Approval for Proclaim Elite SCS System - RTT News
St. Jude Medical to Buy Thoratec for $3.4 Billion
Wall Street Journal - Jul 22, 2015
St. Jude Medical Inc., STJ 0.30 % looking to tap new markets as it grapples with stagnant revenue growth, agreed to pay $3.4 billion in cash to acquire Thoratec Corp.
St. Jude Medical Said in Talks to Buy Implant Maker Thoratec - Bloomberg
Moody's reviews St. Jude Medical's Baa1 rating for downgrade - (press release) (subscription)
St. Jude Medicals Proclaim Elite SCS System Gets FDA Nod - Nov 20, 2015
St. Jude Medical Inc. (STJ - Analyst Report) recently announced the receipt of FDA approval for its new upgradeable and recharge-free Spinal Cord Stimulation (SCS) System - Proclaim Elite.